We are live on ! Find out more
CH

CVI Holdings Portfolio holdings

AUM $116M
1-Year Est. Return 5.68%
This Fund
S&P 500
This Quarter Est. Return
-10.59%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
–
AUM
$44.5M
AUM Growth
-$42.1M
Cap. Flow
-$53.2M
Cap. Flow %
-119.42%
Top 10 Hldgs %
85.41%
Holding
81
New
17
Increased
1
Reduced
6
Closed
38

Top Buys

Rank Stock Value
1
OCGN icon
Ocugen
OCGN
+$4.57M
2
XCUR icon
Exicure
XCUR
+$3.25M
3
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
+$3M
4
TEUM
Pareteum Corporation
TEUM
+$2.51M
5
CRMD icon
CorMedix
CRMD
+$1.93M

Top Sells

Rank Stock Value
1
SCOR icon
Comscore
SCOR
+$14.1M
2
MDCO
Medicines Co
MDCO
+$4.12M
3
CARM
Carisma Therapeutics
CARM
+$3.95M
4
SRNE
Sorrento Therapeutics, Inc.
SRNE
+$3.74M
5
CALA
Calithera Biosciences, Inc
CALA
+$3.29M

Sector Composition

Rank Sector Weight
1 Healthcare 39.19%
2 Technology 6.18%
3 Communication Services 3.83%
4 Consumer Discretionary 1.4%
5 Materials 0.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCRB icon
51
Seres Therapeutics
MCRB
$45M
– –
-11,290
Closed -$727K
MNKD icon
52
PUT
MannKind Corp
MNKD
$1.19B
– –
-15,000
Closed -$17K
NAK
53
Northern Dynasty Minerals
NAK
$773M
– –
-129,963
Closed -$78K
OGEN icon
54
Oragenics
OGEN
$2.24M
– –
-391
Closed -$345K
RGLS
55
DELISTED
Regulus Therapeutics
RGLS
– –
-45,419
Closed -$568K
RKDA icon
56
Arcadia Biosciences
RKDA
$1.42M
– –
-3,377
Closed -$414K
SCOR icon
57
Comscore
SCOR
$113M
– –
-136,426
Closed -$14.1M
SRRK icon
58
Scholar Rock
SRRK
$5.88B
– –
-167,371
Closed -$2.65M
ZYME icon
59
Zymeworks
ZYME
$1.62B
– –
-16,956
Closed -$373K
RDGT
60
Ridgetech Inc
RDGT
$2.79M
– –
-2
Closed -$88K
VTNR
61
DELISTED
Vertex Energy, Inc
VTNR
– –
-10,015
Closed -$15K
CTHR
62
DELISTED
Charles & Colvard Ltd
CTHR
– –
-28,585
Closed -$452K
MOTS
63
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
– –
-46
Closed -$42K
ORTX
64
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
– –
-13,065
Closed -$1.83M
BETS
65
DELISTED
Bit Brother Limited Class A Ordinary Shares
BETS
– –
-2
Closed -$166K
TMDI
66
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
– –
-70,748
Closed -$167K
SRNE
67
DELISTED
Sorrento Therapeutics, Inc.
SRNE
– –
-1,401,640
Closed -$3.74M
ELOX
68
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
– –
-1,860
Closed -$742K
CALA
69
DELISTED
Calithera Biosciences, Inc
CALA
– –
-42,162
Closed -$3.29M
NSPRZ
70
DELISTED
InspireMD, Inc. Series B Warrants
NSPRZ
$0 ﹤0.01%
48,000
– –
UUUU.WS
71
DELISTED
Energy Fuels Inc.
UUUU.WS
$0 ﹤0.01%
277,777
– –
TBIO
72
DELISTED
Translate Bio, Inc. Common Stock
TBIO
– –
-67,464
Closed -$852K
APOPW
73
DELISTED
Cellect Biotechnology Ltd. Warrants to Purchase ADRs
APOPW
$0 ﹤0.01%
12,498
– –
MDCO
74
DELISTED
Medicines Co
MDCO
– –
-112,950
Closed -$4.12M
APDNW
75
DELISTED
Applied DNA Sciences Inc Warrant
APDNW
$0 ﹤0.01%
31,407
– –
1 2
3
4

Similar funds

EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
YSP
Yarra Square Partners New York $111M AUM 41.61% 1-Year Est. Return
GIM
Greenwich Investment Management Norwalk, Connecticut $109M AUM 9.72% 1-Year Est. Return
FWM
FMFE Wealth Management Syracuse, New York $108M AUM
CPG
Custom Portfolio Group Englewood, Colorado $127M AUM
WCM
Windham Capital Management Boston, Massachusetts $128M AUM 12.44% 1-Year Est. Return
ETIA
Epic Trust Investment Advisors Richland, Washington $90.8M AUM 22.03% 1-Year Est. Return
RCM
Rain Capital Management Lake Oswego, Oregon $142M AUM 15.53% 1-Year Est. Return

CVI Holdings's Q3 2019 Portfolio in Review

As of Q3 2019, CVI Holdings held 81 positions worth $44.5M, down 49% from $86.6M the previous quarter. Its ten largest holdings account for 85% of the portfolio.

CVI Holdings withdrew a net $53.2M in Q3 2019, closing 38 positions and reducing 6 holdings. Its most notable exit was Comscore, an estimated $14.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 33% a quarter earlier, followed by Technology and Communication Services.

Against the trend, CVI Holdings opened a new position in Ocugen worth $1.06M.

  • CVI Holdings's largest Q3 2019 buy was Ocugen: 368,315 shares worth $1.06M.
  • CVI Holdings added most to Senmiao Technology Ltd in Q3 2019, an estimated $5.4K increase.
  • CVI Holdings's biggest Q3 2019 reduction was Carisma Therapeutics, cutting an estimated $3.95M.
  • CVI Holdings fully exited Comscore in Q3 2019, selling an estimated $14.1M.
  • CVI Holdings's ten largest holdings make up 85% of its $44.5M portfolio in Q3 2019.
  • CVI Holdings opened 17 new positions and closed 38 in Q3 2019.
  • CVI Holdings's portfolio value fell 49% quarter-over-quarter to $44.5M.

Based on CVI Holdings's 13F filing for Q3 2019, filed 14 Nov 2019.